Back to top

VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

Austin, Texas, United States, July 27th, 2026, FinanceWire VERAXA Biotech (NASDAQ:VRXA) announced the advancement of its bispecific antibody-d...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

OmniAb, Inc. (OABI)